Vivani Medical, Inc.
VANI
$1.33
-$0.03-1.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.37% | 11.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.84% | 0.10% | |||
| Operating Income | -0.84% | -0.10% | |||
| Income Before Tax | 6.05% | -2.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.05% | -2.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.05% | -2.22% | |||
| EBIT | -0.84% | -0.10% | |||
| EBITDA | -0.88% | 0.12% | |||
| EPS Basic | 12.35% | 10.32% | |||
| Normalized Basic EPS | 12.28% | 10.33% | |||
| EPS Diluted | 12.35% | 55.87% | |||
| Normalized Diluted EPS | 12.28% | 10.33% | |||
| Average Basic Shares Outstanding | 7.16% | 13.89% | |||
| Average Diluted Shares Outstanding | 7.16% | 13.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||